PlainRecalls
FDA Devices Critical Class I Ongoing

ENDOTAK RELIANCE G/SG with 4-SITE Connector, transvenous defibrillation lead, Permanent Defibrillator Electrodes; Model Nos. 0282, 0283, 0285, 0286, 0292, 0293, 0295, 0296

Reported: August 27, 2025 Initiated: July 24, 2025 #Z-2326-2025

Product Description

ENDOTAK RELIANCE G/SG with 4-SITE Connector, transvenous defibrillation lead, Permanent Defibrillator Electrodes; Model Nos. 0282, 0283, 0285, 0286, 0292, 0293, 0295, 0296

Reason for Recall

Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.

Details

Units Affected
247,702 US; 344,670 OUS
Distribution
Worldwide Distribution. US nationwide. International distribution worldwide.
Location
Saint Paul, MN

Frequently Asked Questions

What product was recalled?
ENDOTAK RELIANCE G/SG with 4-SITE Connector, transvenous defibrillation lead, Permanent Defibrillator Electrodes; Model Nos. 0282, 0283, 0285, 0286, 0292, 0293, 0295, 0296. Recalled by Boston Scientific Corporation. Units affected: 247,702 US; 344,670 OUS.
Why was this product recalled?
Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 27, 2025. Severity: Critical. Recall number: Z-2326-2025.